Surrozen, Inc. (SRZN)
NASDAQ·Healthcare·Biotechnology
$16.45
-6.53%
Mkt Cap $227.49M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$42.00
Range $40.00 – $44.00
Implied Upside
+155.3%
Consensus $42.00 vs current $16.45
NASDAQ·Healthcare·Biotechnology
$16.45
-6.53%
Mkt Cap $227.49M
No recent rating data.
Price Target (4 analysts)
$42.00
Range $40.00 – $44.00
+155.3%
Consensus $42.00 vs current $16.45